Literature DB >> 10704054

Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.

A L Pukhalsky1, N I Kapranov, E A Kalashnikova, G V Shmarina, L A Shabalova, S N Kokarovtseva, D A Pukhalskaya, N J Kashirskaja, O I Simonova.   

Abstract

Chronic endobronchial inflammation and bacterial infection are the main causes of morbidity and mortality in cystic fibrosis (CF), an autosomal recessive genetic disorder associated with improper function of chloride channels. Inflammation in CF lung is greatly amplified after Pseudomonas aeruginosa infection. In this study the relationship between P. aeruginosa status and inflammatory markers has been investigated. Seventeen CF children in acute lung exacerbation were examined. CF patients without P. aeruginosa infection were characterized by elevated activity of sputum elastase, reduced response of peripheral blood lymphocytes to PHA and significant resistance to the antiproliferative action of glucocorticoids. These parameters were normalized after antibiotic treatment. The patients with prolonged P. aeruginosa infection demonstrated extremely high levels of elastase activity and elevated amounts of sputum IL-8 and TNF-alpha. Although antibiotic treatment resulted in clinical improvement, it failed to suppress excessive immune response in the lung. The data indicate that CF patients with prolonged P. aeruginosa need the modified treatment, which should include immunomodulating drugs and protease inhibitors as well as antibacterial therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10704054      PMCID: PMC1781793          DOI: 10.1080/09629359990496

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  28 in total

Review 1.  Census and consensus in bacterial ecosystems: the LuxR-LuxI family of quorum-sensing transcriptional regulators.

Authors:  C Fuqua; S C Winans; E P Greenberg
Journal:  Annu Rev Microbiol       Date:  1996       Impact factor: 15.500

Review 2.  Quorum sensing by peptide pheromones and two-component signal-transduction systems in Gram-positive bacteria.

Authors:  M Kleerebezem; L E Quadri; O P Kuipers; W M de Vos
Journal:  Mol Microbiol       Date:  1997-06       Impact factor: 3.501

Review 3.  Intercellular communication and group behavior in bacteria.

Authors:  K M Gray
Journal:  Trends Microbiol       Date:  1997-05       Impact factor: 17.079

4.  The use of p-nitrophenyl N-tert-butyloxycarbonyl-L-alaninate as substrate for elastase.

Authors:  L Visser; E R Blout
Journal:  Biochim Biophys Acta       Date:  1972-04-07

Review 5.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

6.  No added benefit from nebulized amiloride in patients with cystic fibrosis.

Authors:  A Graham; A Hasani; E W Alton; G P Martin; C Marriott; M E Hodson; S W Clarke; D M Geddes
Journal:  Eur Respir J       Date:  1993-10       Impact factor: 16.671

7.  Regulation of cytokine secretion by cystic fibrosis airway epithelial cells.

Authors:  C Ruef; D M Jefferson; S E Schlegel-Haueter; S Suter
Journal:  Eur Respir J       Date:  1993-11       Impact factor: 16.671

8.  Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

Authors:  J J Smith; S M Travis; E P Greenberg; M J Welsh
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

Review 9.  Cell-to-cell signaling and Pseudomonas aeruginosa infections.

Authors:  C Van Delden; B H Iglewski
Journal:  Emerg Infect Dis       Date:  1998 Oct-Dec       Impact factor: 6.883

10.  Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa.

Authors:  A Heeckeren; R Walenga; M W Konstan; T Bonfield; P B Davis; T Ferkol
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

View more
  7 in total

1.  Mechanism of fibroblast inflammatory responses to Pseudomonas aeruginosa elastase.

Authors:  Ali O Azghani; Kourtney Neal; Steven Idell; Rodolfo Amaro; Jason W Baker; Abdelwahab Omri; Usha R Pendurthi
Journal:  Microbiology (Reading)       Date:  2014-01-02       Impact factor: 2.777

Review 2.  Monitoring inflammation in CF. Cytokines.

Authors:  Scott D Sagel; Frank J Accurso
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

3.  Neutrophil cell death, activation and bacterial infection in cystic fibrosis.

Authors:  A P Watt; J Courtney; J Moore; M Ennis; J S Elborn
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

Review 4.  Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Authors:  Scott D Sagel; James F Chmiel; Michael W Konstan
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

5.  Improvement of nutrient absorption may enhance systemic oxidative stress in cystic fibrosis patients.

Authors:  G V Shmarina; A L Pukhalsky; S N Kokarovtseva; D A Pukhalskaya; E A Kalashnikova; N I Kapranov; N J Kashirskaja
Journal:  Mediators Inflamm       Date:  2001-04       Impact factor: 4.711

6.  Extracellular ATP inhibits twitching motility-mediated biofilm expansion by Pseudomonas aeruginosa.

Authors:  Laura M Nolan; Rosalia Cavaliere; Lynne Turnbull; Cynthia B Whitchurch
Journal:  BMC Microbiol       Date:  2015-03-01       Impact factor: 3.605

7.  Cystic fibrosis-adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses.

Authors:  Shantelle L LaFayette; Daniel Houle; Trevor Beaudoin; Gabriella Wojewodka; Danuta Radzioch; Lucas R Hoffman; Jane L Burns; Ajai A Dandekar; Nicole E Smalley; Josephine R Chandler; James E Zlosnik; David P Speert; Joanie Bernier; Elias Matouk; Emmanuelle Brochiero; Simon Rousseau; Dao Nguyen
Journal:  Sci Adv       Date:  2015-07-31       Impact factor: 14.136

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.